• 产品
  • 供应商
  • CAS号
  • 采购
  • 资讯
  • 会展活动

您的位置:首页 >> 制药产品大全 >> 药品制剂 >> 心脑血管制剂 >> Enoxaparin sodium injection

Enoxaparin sodium injection

Enoxaparin sodium injection

更新时间:2021-11-23
地区:四川省
最小起订量:
月产量:
工厂所在地:Chengdu,Sichuan,China
详细描述
  • 主要销售市场:北美洲,中/南美洲,西欧,东欧,大洋洲,亚洲,中东,非洲
  • 提供样品:
产品描述:

Active ingredients: enoxaparin sodium, molecular weight: average molecular weight is between 3800-5000 daltons.
Description: clear, colorless to pale yellow clear liquid.      

Dosage Form: liquid injection.                                                                           
Indications:

1. Prophylaxis of venous thromboembolic diseases (the generation of venous thrombosis), specially orthopedic or general surgery-related thrombosis;

2. For acute deep vein thrombosis, with or without pulmonary embolism and when symptoms are not obvious. Exclude pulmonary embolism which requires surgery and thrombolytic therapy;

3. Treatment of unstable Angina and Non-Q-Wave Myocardial infarction, when concurrently administered with aspirin;

4. Hemodialysis in vitro circulation, to prevent thrombosis.
Strength:0.6ml:6000AxaIU

Storage: Keep airtight in a cool place.
Packaging: 10 bottles/box, 100 boxes/carton (Can be customized based on customer's order.)

Shelf Life: 24months.

地址:

城市:

联系人:

电话:

传真:

成为供应商 在线获取商机 申请入驻
快速询盘
心脑血管类制剂
CPHI制药在线为您找到Enoxaparin sodium injection价格、Enoxaparin sodium injection详细参数、Enoxaparin sodium injection相关产品、Enoxaparin sodium injection供应商等信息,想了解当前Enoxaparin sodium injection最新报价,请联系四川宏明博思药业有限公司
CPHI 网上贸易平台: CPHI.cn| Pharmasources.com| CPHI-Online.com
客服热线:  86-400 610 1188 (周一至周五 9: 00-18: 00)